Patents Assigned to Universiteit Antwerp
  • FAP inhibitors
    Patent number: 9346814
    Abstract: The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in particular for the treatment and/or prevention of FAP-related disorders such as but not limited to proliferative disorders.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: May 24, 2016
    Assignees: Universiteit Antwerp, Fox Chase Cancer Center
    Inventors: Koen Jansen, Ingrid De Meester, Leen Heirbaut, Jonathan D Cheng, Jurgen Joossens, Koen Augustyns, Pieter Van Der Veken